Viewing Study NCT04323202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT04323202
Status: COMPLETED
Last Update Posted: 2025-10-24
First Post: 2020-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Basal Cell Carcinoma of the Head and Neck View
Keywords: